Riskpilot← Back to searchSign inGet full accessSENTRUMSLEGENE HØNEFOSS AS
ASActiveOrg 921170661Inngang Fra Blomsgate Storgata 13, 3510 HønefossGeneral medical practice activities · NACE 8621Est. 20185 employees
Revenue 2024
NOK 4,1M
+53% vs 2023
EBITDA margin
4.6%
+294% vs 2023
Equity ratio
18.8%
Financial strength
Net profit 2024
NOK 201K
+260% vs 2023
| Revenue | NOK 4,1M | +53% |
| EBITDA | NOK 188K | +294% |
| Net profit | NOK 201K | +260% |
| Total assets | NOK 807K | +14% |
| Equity | NOK 152K | +406% |
| Employees | 5 | — |
Legal name
SENTRUMSLEGENE HØNEFOSS AS
Org number
921170661
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. juli 2018
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Legevirksomhet, kjøp og salg av fast eiendom, investering i andre selskaper, verdipapirer og virksomhet som naturlig hører inn under dette.
Address
Inngang Fra Blomsgate Storgata 13, 3510 Hønefoss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 748 | 1 785 | 1 658 | 2 679 | 4 106 |
| Staff expenses | −798 | −852 | −875 | −1 238 | −1 895 |
| EBITDA | 96 | 235 | −10 | −97 | 188 |
| Depreciation & amort. | −44 | −44 | −44 | −27 | −7 |
| EBIT | 52 | 191 | −54 | −124 | 180 |
| Net financials | −7 | −6 | −5 | −2 | 26 |
| Profit before tax | 44 | 185 | −59 | −126 | 206 |
| Tax | 10 | 41 | 4 | −0 | 5 |
| Net profit | 35 | 144 | −63 | −126 | 201 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 355 | 423 | 615 | 710 | 807 |
| Equity | −5 | 139 | 76 | −49 | 152 |
| Long-term debt | 124 | 92 | 60 | 29 | 0 |
| Short-term debt | 236 | 192 | 478 | 731 | 656 |
| Total debt | 360 | 284 | 538 | 759 | 656 |
EBITDA margin
4.6%
This company
15.8%
Market median
-71% vs market
20202024
Equity ratio
18.8%
This company
38.2%
Market median
-51% vs market
20202024
Return on equity
132.6%
This company
18.4%
Market median
+621% vs market
20202024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20202024
Asset turnover
5.09×
This company
1.12×
Market median
+354% vs market
20202024
Debt / equity
4.33×
This company
0.62×
Market median
-598% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Guttormsen Holding As
SENTRUMSLEGENE HØNEFOSS AS Board members of SENTRUMSLEGENE HØNEFOSS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eline Redner Tverran | Board of Directors | 0 companies |
| Jørgen Gotteberg Christensen | Board of Directors | 0 companies |
| Ingunn Jullum Leiknes | Board of Directors | 0 companies |
| Gaute Johnsrud Guttormsen | Chairman | 0 companies |